401 B Street, Suite 2450
San Diego, California 92101
11011 NE Boulder Place
Bainbridge Island, Washington 98110
Kathryn Karcher practices appellate law in federal courts and in California and Washington state courts. Ms. Karcher is a Certified Appellate Specialist by the California Board of Legal Specialization, is the President of the California Academy of Appellate Lawyers, and is Vice-Chair of the San Diego County Bar Association’s Appellate Practice Section.
Ms. Karcher has received the “Street Fighter of the Year” award from the Consumer Attorneys of California for excellence in representing plaintiffs on appeal.
Ms. Karcher has been included in San Diego Super Lawyers and The Best Lawyers in America for many years. She has consistently been named one of the Super Lawyers Top 25 Women Lawyers in San Diego County and has been recognized as a Southern California Super Lawyer, one of the Top 50 San Diego Super Lawyers, and a Washington Super Lawyer. Karcher Harmes has also been included in U.S. News and World Report’s “Best Law Firms” in Appellate Practice for years.
Ms. Karcher’s professional activities include serving as Chair of the State Bar of California Appellate Courts Committee and the San Diego County Bar Association’s Appellate Court Committee. She has served on the Appellate Law Advisory Commission to the California Board of Legal Specialization on which she assisted with writing the appellate law specialist exam and reviewing applications for certification as an appellate specialist. Ms. Karcher has served as a member of the Board of Directors of the California Supreme Court Historical Society and was a founding member of the Gerald Brown Appellate Inn of Court. She has spoken on numerous topics in appellate law and was a Chapter Editor of the California Appellate Practice Handbook (6th and 7th Editions).
From 2005 through 2007 Ms. Karcher chaired the Appellate Practice Group at DLA Piper. From 1995 through 2007 she was a partner there and at its predecessor Gray Cary Ware & Freidenrich. In 2008 Ms. Karcher opened a private practice in appellate law. In mid-2010 she and her husband, Jeff Harmes, formed Karcher Harmes LLP, and in 2012 they formed Karcher Harmes PS. They maintain offices in San Diego, California, and Bainbridge Island, Washington.
Jeff Harmes concentrates his practice in business law. He focuses on licensing and commercialization of intellectual property, outsourcing, and complex commercial agreements.
Mr. Harmes has negotiated complex development, licensing, distribution, and strategic alliance agreements in a wide variety of industries including software, automotive, medical devices, pharmaceuticals, electronic games, communications, and electronic commerce. He has assisted with establishment of foreign distribution networks and joint ventures worldwide, including in Asia, Europe, Canada, and Central America, and has participated as both lead counsel and intellectual property counsel in numerous significant merger and acquisition transactions.
Mr. Harmes is a 2015 Top Rated Lawyer in Technology Law by Martindale-Hubbell™ and is included in The Best Lawyers in America for Copyright Law and The Best Lawyers in America for 2015. From 1988 through 2000 Mr. Harmes was a partner at the Tonkon Torp law firm in Portland, Oregon, where he served as Chair of the Business Transactions practice group. From 2000 through 2006 he was a partner at DLA Piper and its predecessor firm, Gray Cary Ware & Freidenrich, and was Managing Partner of its Seattle office from 2001 through 2006. From 2006 through mid-2010 Mr. Harmes was a partner at KL Gates and its predecessor firm Preston Gates & Ellis, where he served as Chair of the Licensing and Electronic Transactions practice group through 2009.
Mr. Harmes’ professional activities have included serving on the boards of the University of Washington’s Shidler Center for Law, Commerce & Technology and Bainbridge Island Public Television. He has been a frequent speaker on a variety of technology-related topics and is co-author of a chapter for a legal treatise regarding the commercialization of medical devices.